Print This Page Bookmark and Share
Publications Pain Management Pain Management SMA12-4682
An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

SAMHSA Advisory, Winter 2012

Add To Favorites

Advisory - In Stock

Download Digital Version

/18
Write a Comment
Price: FREE (shipping charges may apply)

Standard shipping is free. Expedited delivery has associated costs. You will be able to review shipping options and costs during check-out.


Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.



Pub id: SMA12-4682
Publication Date: 2/2012
Popularity: 107
Format: Advisory
Audience: Professional Care Providers
Series: SAMHSA Advisory

You May Also Be Interested In

Write a Comment

Fields marked with an * are required.

com.iqsolutions.pinnacle.dto.user.MyAccountDtoImpl@19abd5b


For any questions regarding product availability or ordering methods, please review our Help Page. To be considered for public posting, comments should be geared towards helping visitors assess the quality of this content, and must adhere to the HHS Comment Policy.


Type the case-sensitive characters you see in the picture below.


Customer Comments

Comment by:

02/27/2012 9:45 AM

Anonymous customer said:

Great resource!

Comment by:

03/05/2012 6:42 PM

Anonymous customer said:

good inormation

Comment by:

03/14/2012 3:33 PM

Anonymous customer said:

No mention of the cost of therapy--over a thousand dollars a month. It is this type of treatment that is bankrupting this country and raising insurance rates to astronomic levels.

Comment by:

03/19/2012 2:48 PM

Anonymous customer said:

This Advisory is helpful.

Comment by:

07/16/2012 4:09 PM

A professional from a Treatment Facility said:

Thank you for the information which I am sure will help us with our attempt to implement the usage of Vivitrol in our programs

Comment by:

07/17/2012 2:24 PM

A professional from a School/University said:

I like being well informed and upto date.

Comment by:

01/30/2013 11:17 AM

A professional from a Individual/Group Practice said:

Great website with wonderful resources

Patient and Family-friendly links from NIH